Clinical Trials for MapLight Therapeutics

Explore 4 clinical trials worldwide

Showing 1-4 of 4 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: MapLight Therapeutics

Clinical Trials (4)

NCT06887192
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
PHASE2Recruiting
300 participants
Started: Aug 15, 2025 · Completed: Feb 28, 2027
1 condition1 sponsor16 locations
NCT07038876
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Inpatient Adults With Schizophrenia
PHASE2Recruiting
300 participants
Started: Jun 27, 2025 · Completed: Jan 31, 2027
1 condition1 sponsor25 locations
NCT05889273
ML-004 Open-Label Extension Study in Adults and Adolescents With Autism Spectrum Disorders (ASD)
PHASE2Enrolling by invitation
120 participants
Started: Jun 1, 2023 · Completed: Dec 31, 2027
1 condition1 sponsor17 locations
NCT05081245
ML-004 in Adolescents and Adults With Autism Spectrum Disorders (ASD)
PHASE2Recruiting
150 participants
Started: Sep 13, 2022 · Completed: Nov 30, 2026
1 condition1 sponsor41 locations